Synthesis of a Naphthyridone p38 MAP Kinase Inhibitor

Compound 1 is a p38 MAP kinase inhibitor potentially useful for the treatment of rheumatoid arthritis and psoriasis. A novel six-step synthesis suitable for large-scale preparation was developed in support of a drug development program at Merck Research Laboratories. The key steps include a tandem H...

Full description

Saved in:
Bibliographic Details
Published inJournal of organic chemistry Vol. 71; no. 22; pp. 8602 - 8609
Main Authors Chung, John Y. L, Cvetovich, Raymond J, McLaughlin, Mark, Amato, Joseph, Tsay, Fuh-Rong, Jensen, Mark, Weissman, Steve, Zewge, Daniel
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 27.10.2006
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compound 1 is a p38 MAP kinase inhibitor potentially useful for the treatment of rheumatoid arthritis and psoriasis. A novel six-step synthesis suitable for large-scale preparation was developed in support of a drug development program at Merck Research Laboratories. The key steps include a tandem Heck-lactamization, N-oxidation, and a highly chemoselective Grignard addition of 4-(N-tert-butylpiperidinyl)magnesium chloride to a naphthyridone N-oxide. The N-oxide exerted complete chemoselectivity via chelation in directing the Grignard addition to the α position as opposed to 1,4-addition on the ene-lactam. The dihydropyridyl adduct was in situ aromatized with isobutylchloroformate followed by heating in pyridine. Syntheses of Grignard precursor, N-tert-butyl-4-chloro-piperidine, were accomplished via transamination with a quaternary ammonium piperidone or via addition of methylmagnesium chloride to an iminium ion. Utilizing this chemistry, multi-kilogram preparation of compound 1 was successfully demonstrated.
Bibliography:istex:F4703D07D72DE41278B0BC1E5A30942011FA6941
ark:/67375/TPS-QB8RCS0F-0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3263
1520-6904
DOI:10.1021/jo061618f